MedTrace Logo

Fecal Microbiota Transplantation in Postoperative Crohn's Disease

NCT04637438 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-10-27

No results posted yet for this study

Summary

This pilot study aims to detect possible trends or signals suggesting efficacy of FMT on prevention of delay of POR, to determine the safety of FMT in post operative CD, and asses if a full randomised controlled trial is feasible in this setting. With microbiota analysis we aim to assess if changes in gut microbiota are related to disease course of CD after operation.

Conditions

  • Crohn Disease

Interventions

OTHER

Fecal Microbiota Transplantation

FMT via colonoscopy

OTHER

Placebo

Water infusion via colonoscopy

Sponsors & Collaborators

  • Turku University Hospital

    collaborator OTHER_GOV

  • Joint Authority for Päijät-Häme Social and Health Care

    collaborator OTHER

  • Kuopio University Hospital

    collaborator OTHER

  • Helsinki University Central Hospital

    collaborator OTHER

  • Tampere University

    collaborator OTHER

  • Tampere University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-18
Primary Completion
2023-12-31
Completion
2027-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04637438 on ClinicalTrials.gov